All In Biotech

Drug Trial Radar · NCT06378697

A Phase III Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis

A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Clinical Study to Evaluate the Efficacy and Safety of AK111 in the Treatment of Subjects With Active Ankylosing Spondylitis

Last checked: Nov 19, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 510 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

510

Actual

Start

Nov 22, 2023

Primary completion

Feb 19, 2025

Study completion Nov 7, 2025

Sponsor

Lead sponsor
AkesoIndustry
Sponsor type
Industry
First posted
Apr 22, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized, double-blind, placebo-controlled, multi-center phase III clinical study to evaluate the efficacy and safety of AK111 in the treatment of subjects with active ankylosing spondylitis.

Conditions

  • Ankylosing Spondylitis

Interventions

  • AK111Drug

    Drug: AK111 subcutaneous injection at week 0,1, 4 and 4-weekly thereafter until week 48.

  • Placebo+AK111Drug

    Placebo+AK111 placebo subcutaneous injection at week 0,1, 4,8 and 12 follow AK111 4-weekly thereafter until week 48.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. the response rate of ASAS20Time frame: week 16

Locations

60 sites in 1 country. Site status is shown where the registry gives one.

  • 1006-The First Affiliated Hospital of Bengbu Medical University

    Bengbu, Anhui, China

  • 1038-Anhui Provincial Hospital

    Hefei, Anhui, China

  • 1001-Peking University Third Hospital

    Beijing, Beijing Municipality, China

  • 1002-Xuanwu Hospital Capital Medical University

    Beijing, Beijing Municipality, China

  • 1042-Peking University Shougang Hospital

    Beijing, Beijing Municipality, China

  • 1061-Beijing Tiantan Hospital

    Beijing, Beijing Municipality, China

  • 1049-The First Affiliated Hospital of Xiamen University

    Xiamen, Fujian, China

  • 1027-Lanzhou University Second Hospital

    Lanzhou, Gansu, China

  • 1005-Nanfang Hospital

    Guangzhou, Guangdong, China

  • 1025-Guangzhou First People's Hospital

    Guangzhou, Guangdong, China

  • 1030-Jieyang People's Hospital

    Jieyang, Guangdong, China

  • 1008-The Seventh Affiliated Hospital, Sun Yat-sen University

    Shenzhen, Guangdong, China

  • 1026-Shenzhen People's Hospital

    Shenzhen, Guangdong, China

  • 1056-Zhongshan Traditional Chinese Medicine Hospital

    Zhongshan, Guangdong, China

  • 1060-The First Affiliated Hospital of Guilin Medical University

    Guilin, Guangxi, China

  • 1024-Liuzhou People's Hospital

    Liuzhou, Guangxi, China

  • 1021-The People's Hospital of Guangxi Zhuang Autonomous Region

    Nanning, Guangxi, China

  • 1057-The Second Affiliated Hospital of Guangxi Medical University

    Nanning, Guangxi, China

  • 1022-The First Affiliated Hospital of Hainan Medical University

    Haikou, Hainan, China

  • 1034-Affiliated Hospital of Hebei University

    Baoding, Hebei, China

  • 1012-Hebei Petro China Central Hospital

    Langfang, Hebei, China

  • 1029-Hebei General Hospital

    Shijiazhuang, Hebei, China

  • 1033-The First Hospital of Qiqihar

    Qiqihar, Heilongjiang, China

  • 1045-The First Affiliated Hospital of Henan University of Science and Technology

    Luoyang, Henan, China

  • 1053-Nanyang Central Hospital

    Nanyang, Henan, China

  • 1051-Shiyan People's Hospital

    Shiyan, Hubei, China

  • 1031-The First Affiliated Hospital of University of South China

    Hengyang, Hunan, China

  • 1032-Yueyang Central Hospital

    Yueyang, Hunan, China

  • 1011-Zhuzhou Central Hospital

    Zhuzhou, Hunan, China

  • 1017-Changzhou NO.2 People's Hospital

    Changzhou, Jiangsu, China

  • 1037-The Second People's Hospital of Lianyungang

    Lianyungang, Jiangsu, China

  • 1004-Zhongda Hospital Southeast University

    Nanjing, Jiangsu, China

  • 1007-Nanjing Drum Tower Hospital

    Nanjing, Jiangsu, China

  • 1036-Jiangsu Province Hospital

    Nanjing, Jiangsu, China

  • 1018-Affiliated Hospital of Nantong University

    Nantong, Jiangsu, China

  • 1035-Wuxi People's Hospital

    Wuxi, Jiangsu, China

  • 1013-Xuzhou Central Hospital

    Xuzhou, Jiangsu, China

  • 1014-Affiliated Hospital of Jiangsu University

    Zhenjiang, Jiangsu, China

  • 1047-The First Affiliated Hospital of Gannan Medical College

    Ganzhou, Jiangxi, China

  • 1020-The Second Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, China

Showing 40 of 60 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.